Litcius/Paper detail

Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease

Syed Obaidur Rahman, Madhu Kaundal, Mohd Salman, Apeksha Shrivastava, Suhel Parvez, Bibhu Prasad Panda, Mymoona Akhter, Mohd Akhtar, Abul Kalam Najmi

2020European Journal of Pharmacology38 citationsDOI

Topics & Concepts

AlogliptinInsulin resistanceAmyloid betaBETA (programming language)Amyloid (mycology)Alzheimer's diseaseHippocampal formationDiseaseInsulinFibrilChemistryAmyloid fibrilInternal medicineNeuroscienceMedicineBiophysicsAmyloid βBiochemistryPathologyBiologyComputer scienceSitagliptinMetforminProgramming languageAlzheimer's disease research and treatmentsDiabetes Treatment and ManagementNeuropeptides and Animal Physiology
Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease | Litcius